This binding is necessary for the absorption of Vitamin B12, and when there is a lack of it, the body cannot absorb the vitamin efficiently, leading to deficiency
It is dispensed in amber multidose vials containing 1,000 mcg/mL and compounded for use under either section 503A or 503B, allowing clinicians to individualize therapy for deficiency states ranging from pernicious anemia to postsurgical malabsorption
Additionally, research published in Drug Testing and Analysis characterizing AOD9604 metabolism and confirming its C-terminal HGH fragment structure, supporting its classification as a non-IGF-1-stimulating lipolytic agent has been used by clinicians evaluating the compound for metabolic applications
Selective inhibitor of nicotinamide N-methyltransferase (NNMT)
Do not place loose sharps in household trash
Choosing the right treatment depends on absorption, severity of deficiency, lifestyle, and underlying medical conditions